Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
5(63%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_2
3
38%
Ph not_applicable
4
50%
Ph phase_1
1
13%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
3(37.5%)
N/ANon-phased studies
4(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

5

trials recruiting

Total Trials

8

all time

Status Distribution
Active(5)
Completed(2)
Terminated(1)

Detailed Status

Recruiting3
Active, not recruiting2
Completed2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
5
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (12.5%)
Phase 23 (37.5%)
N/A4 (50.0%)

Trials by Status

active_not_recruiting225%
terminated113%
completed225%
recruiting338%

Recent Activity

5 active trials
Showing 5 of 8
active_not_recruitingphase_1

Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy

NCT04387084
recruitingphase_2

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

NCT07202247
active_not_recruitingphase_2

Metformin and Nightly Fasting in Women With Early Breast Cancer

NCT05023967
recruitingnot_applicable

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

NCT05312255
recruitingphase_2

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

NCT05722288
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT04387084Phase 1

Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy

Active Not Recruiting
NCT07202247Phase 2

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

Recruiting
NCT05023967Phase 2

Metformin and Nightly Fasting in Women With Early Breast Cancer

Active Not Recruiting
NCT05312255Not Applicable

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Recruiting
NCT05722288Phase 2

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

Recruiting
NCT00936364Not Applicable

Short-Term Fasting: Impact on Toxicity

Terminated
NCT04557540Not Applicable

Weight Loss Interventions for Black Adults of Faith

Completed
NCT01304251Not Applicable

Effects of Short-term Fasting on Tolerance to Chemotherapy

Completed

All 8 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
8